Contact
- workRoom B1A06 B1
Malaysia Campus
Jalan Broga
43500 Semenyih
Selangor Darul Ehsan
Malaysia - work+6 (03) 8725 3422
- FeiLing.Yap@nottingham.edu.my
Biography
I obtained my Ph.D. in Stem Cell and Cancer Immunotherapy from International Medical 188体育网址_188体育在线-【唯一授权网站】@, Malaysia while working as a trainee lecturer there. After completing my Ph.D. I worked as a lecturer and started supervising undergraduate students from medical, pharmacy and life sciences programs. Subsequently, I received training on induced pluripotent stem cells at the Center for IPS Cell 188体育网址_188体育在线-【唯一授权网站】@ and Application, Kyoto 188体育网址_188体育在线-【唯一授权网站】@, Japan. Prior to join the 188体育网址_188体育在线-【唯一授权网站】@ of Nottingham Malaysia, I had worked in National Institutes of Health as well as a senior lecturer in SEGI 188体育网址_188体育在线-【唯一授权网站】@, Malaysia. I was mainly involved in teaching Immunology, Pathology and Physiology modules for medical, dentistry, optometry and life sciences students, as well as Master of Science students.
Teaching Summary
As a new faculty in UNM, at the moment, I am involved in the teaching of Microbiology (LIFE 2102), Biochemistry of Disease (LIFE 3054) and Therapeutic Immunology (LIFE4130) modules for biomedical… read more
188体育网址_188体育在线-【唯一授权网站】@ Summary
My previous PhD project was focused on generation of genetically engineered stem cells and study their efficacy against breast cancer. My research areas of interest are primarily on stem cell… read more
As a new faculty in UNM, at the moment, I am involved in the teaching of Microbiology (LIFE 2102), Biochemistry of Disease (LIFE 3054) and Therapeutic Immunology (LIFE4130) modules for biomedical sciences students.
Current 188体育网址_188体育在线-【唯一授权网站】@
My previous PhD project was focused on generation of genetically engineered stem cells and study their efficacy against breast cancer. My research areas of interest are primarily on stem cell immunology, cell based therapy and cancer immunotherapy. My current works include development of gene modified cell based therapies for various cancer and lineage differentiation of reprogrammed stem cells for regenerative medicine.
